Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells☆M. Emmy M. Dolman, Robbert J. Kok, Wim E. Hennink et al.|Advanced Drug Delivery Reviews|2010Cited by 153
Characterization of drug-lysozyme conjugates by sheathless capillary electrophoresis–time-of-flight mass spectrometryRob Haselberg, Govert W. Somsen, Robbert J. Kok et al.|Analytica Chimica Acta|2011Cited by 39
Development of a Cell-Selective and Intrinsically Active Multikinase Inhibitor BioconjugateStefan Harmsen, Robbert J. Kok, M. Emmy M. Dolman et al.|Bioconjugate Chemistry|2011Cited by 20
Kinase Inhibitor ConjugatesStefan Harmsen, Robbert J. Kok|Current Pharmaceutical Design|2012Cited by 9
Targeting of a platinum-bound sunitinib analog to renal proximal tubular cellsRobbert J. Kok, G Storm, Hennink WE et al.|DOAJ (DOAJ: Directory of Open Access Journals)|2012Cited by 0